Access for Life

Access for Life, founded in 2015, is a medical device startup based in the United States. The company, with the slogan "The JEM represents an innovative breakthrough in the field of repetitive vascular access and real-time data gathering," addresses the challenge of vascular access in chronic care patients, such as those undergoing hemodialysis, which often leads to clinical complications and increased healthcare costs. The JEM™ is the company's patented Smart device that aims to become the "Gold Standard" for safe venous access and preservation of the AV fistula or graft, along with real-time data gathering. The innovative features of the JEM™ include acting as a needle guide to safely direct a needle into the vein, reducing vessel damage and patient pain. It allows less skilled caregivers to assist patients or enables patients to perform self-care hemodialysis, thereby promoting home-based treatments. Additionally, the device transmits monitoring data on the patient’s vascular system and gathers real-time data on the dialysis process, contributing to predictive and preventive care. Access for Life received non-equity assistance investment from MassChallenge on 19 October 2016. The disruptive and innovative nature of the JEM™ positions the company to significantly reduce healthcare system costs associated with the repair and replacement of AV fistulas, making it a promising investment opportunity.